Clinical trials
Active, not recruiting Phase 2 trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
511 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2008 | 1 |
| 2015 | 3 |
| 2016 | 2 |
| 2017 | 6 |
| 2018 | 6 |
| 2019 | 12 |
| 2020 | 37 |
| 2021 | 46 |
| 2022 | 72 |
| 2023 | 82 |
| 2024 | 106 |
| 2025 | 96 |
| 2026 | 42 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 511 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Sun Yat-sen University | 37 |
| Fudan University | 19 |
| Novartis Pharmaceuticals | 14 |
| Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 13 |
| AstraZeneca | 12 |
| Institute of Hematology & Blood Diseases Hospital, China | 10 |
| Sichuan Baili Pharmaceutical Co., Ltd. | 10 |
| Peking Union Medical College Hospital | 8 |
| Sanofi | 8 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 8 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 48 |
| Breast Neoplasms | 24 |
| Squamous Cell Carcinoma of Head and Neck | 15 |
| Esophageal Squamous Cell Carcinoma | 13 |
| Colorectal Neoplasms | 12 |
| Nasopharyngeal Carcinoma | 11 |
| Stomach Neoplasms | 11 |
| Rectal Neoplasms | 10 |
| Carcinoma, Hepatocellular | 9 |
| Hepatitis B, Chronic | 9 |
Trials
Showing 1 to 25 of 511. Each trial links to its page on Pharma Observatory.
411 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.